United States Vaccine Market, Forecast By Type & Companies

1
United States Vaccine Market
United States Vaccine Market
2
Report Description and Highlights
The average human life span has grown
significantly primarily due to vaccination.
Vaccines have transformed public health
throughout the world, especially for children. In
the United States, among the various diseases
like Influenza, Rotavirus, Hepatitis (Hepatitis A
and Hepatitis B), Polio, DTap, HIB, Pneumococcal
conjugate, Varicella, MMR and HPV, influenza is
the most common viral infection. Quadrivalent is
the most common flu vaccines in the United
States, which was licensed in the year 2012.
According to Renub Research, United States
Vaccine Market is poised to reach US 11.4
Billion by 2026.
United States Vaccine Market
3
United States Vaccine Market
Although influenza can catch anyone anytime in
the year, usually it spreads between May to
October. So in August National Immunization
Awareness day is being celebrated to increase the
awareness and the importance of vaccination in
the nation. These immunizations awareness and
government initiatives have helped to prevent 2-3
million deaths annually according to the World
Health Organisation. There is no other health
intervention as simple, powerful, and
cost-effective as a vaccine. In this report,
we have studied key players like GlaxoSmithKline,
plc, Merck Co, Sanofi Pasteur and Pfizer, Inc
their trends and implication which has given
these companies to view in a strategic way. Apart
from that, companies are evaluated on parameters
like     Overviews     Recent
Developments    Revenues     Vaccinations
Pipeline Clinical Trials
Request a free sample copy of the report
https//www.renub.com/request-sample-page.php?gtur
lunited-states-vaccine-market-p.php
United States Vaccine Market
4
United States Vaccine Market
Renub Research report titled United States
Vaccine Market By Vaccine Type (Vaccines Market,
Immunized Population and Administered Doses),
Influenza (Trivalent Flu Vaccine and Quadrivalent
Flu Vaccine), Retrovirus, Hepatitis (Hepatitis A
and B), Polio, DTap, HIB, Pneumococcal Conjugate,
Varicella, MMR and HPV) Vaccines Products and
Pipeline, Company Analysis (GlaxoSmithKline, plc,
Merck Co, Sanofi Pasteur and Pfizer,
Inc.) provides an all-encompassing analysis on
the United States Vaccine Industry.
Request a free Brochure copy of the report
https//www.renub.com/request-brochure-page.php?gt
urlunited-states-vaccine-market-p.php
United States Vaccine Market
5
United States Vaccine Market
Forecast for United States Vaccine Market Share
() - by Type (2020 - 2026)
Source Renub Research Analysis Note
These are dummy figures actual data given in the
report
United States Vaccine Market
6
United States Vaccine Market
All the 10 Vaccines have been studied from 3
points     Vaccines Market    Immunized
Population (Infants)    Doses of Vaccines
Administered Vaccine Type - The Report Covers
the Market, Immunized Population and Administered
Doses of all the 10 diseases 1.    Influenza
Vaccines 2.    Retrovirus3.    Hepatitis A
B 4.    Polio5.    DTaP 6.    HIB7.  
 Pneumococcal conjugate 8.    Varicella9.  
 MMR 10.    HPV
United States Vaccine Market
7
United States Vaccine Market
Forecast for United States Vaccine Volume Share
() - by Type (2020 - 2026)
Source Renub Research Analysis Note
These are dummy figures actual data given in the
report
United States Vaccine Market
8
United States Vaccine Market
All the company analysis has been covered from 4
Viewpoints     Overview    Recent
Developments    Revenue Analysis  
 Vaccinations Pipeline Clinical Trials Company
Analysis     GlaxoSmithKline, plc    Merck
Co    Sanofi Pasteur    Pfizer, Inc.
United States Vaccine Market
9
United States Vaccine Market
United States Vaccine Market
10
Contact Us
United States Vaccine Market